Antibodies
Candidate binders against the exact site you want, from your antigen sequence alone. No animal, no display library, and no waiting to find out which epitope the biology happened to pick.
Miniprotein binders
A fraction of the size and of the cost to express, against the same epitope. For when an antibody scaffold is more than your target actually needs.
Antibody humanization
Cut immunogenicity risk without paying for it in affinity. We hold the residues that carry the binding site, and prove it against the parent molecule.
Developability optimization
Kill the candidates that would fail at formulation before they cost you a year, and re-engineer the ones worth saving.
Cross-reactivity
Bind the species your preclinical package needs. Miss the paralogue that would sink it. Both are specified at design time, not discovered at the end.
Affinity maturation
Tighter binding without a display campaign. We model the interface, rank the substitutions, and hand you tens of candidates instead of a library.
